Medicine and Dentistry
Overall Survival
100%
Cohort Analysis
82%
Multiple Myeloma
82%
MALT Lymphoma
45%
Hospital Care
41%
Lenalidomide
41%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
41%
Submandibular Gland
41%
Parotid Gland
41%
Ibrutinib
41%
Glioblastoma
41%
Natural Killer Cell
41%
Survival Rate
40%
Quinolone Derivative
31%
Penicillin
31%
Large-Cell Lymphoma
25%
Follicular Lymphoma
25%
Melphalan
20%
Drug Megadose
20%
Autologous Stem Cell Transplantation
20%
Bacterial Colonization
20%
Macrolide
20%
Autoimmune Disease
20%
Progression Free Survival
17%
Magnetic Resonance Imaging
13%
Log Rank Test
12%
Medical Record
12%
Proportional Hazards Model
12%
Kaplan Meier Method
12%
Multivariate Analysis
10%
Subgroup Analysis
10%
Antibiotic Resistance
10%
Enterobacteriaceae
10%
Antibiotic Therapy
10%
Methicillin Resistant Staphylococcus Aureus
10%
Emergency Department
10%
Prevalence
10%
Carbapenemase
10%
Beta-Lactamase
10%
Case-Control Study
10%
Immunosurveillance
10%
T Cell
10%
Diseases
9%
Waldenström's Macroglobulinemia
9%
Monotherapy
9%
Biopsy Technique
9%
Clinical Trial
8%
Survival Analysis
6%
Incidence (Epidemiology)
6%
Cohort Effect
5%
Immunology and Microbiology
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
41%
Natural Killer Cell
41%
Multiple Myeloma
41%
Penicillin
31%
Bacterial Colonization
20%
Nose
10%
Methicillin-Resistant Staphylococcus Aureus
10%
T Cell
10%
Prevalence
10%
Antimicrobial Resistance
10%
Enterobacteriaceae
10%
Rectum
10%
Immunosurveillance
10%
Cytotoxicity
5%
Immunotherapy
5%
B Cell
5%
Effector Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
41%
Multiple Myeloma
41%
Quinolone Derivative
31%
Penicillin
31%
Macrolide
20%
Enterobacteriaceae
10%
Prevalence
10%
Methicillin-Resistant Staphylococcus Aureus
10%
Carbapenemase
10%
Case-Control Study
10%
Antimicrobial Resistance
10%
Immunotherapy
5%
Diseases
5%
Clinical Trial
5%
Cytotoxicity
5%
Hematologic Malignancy
5%
